Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion?

  • Mike Greaves
  • Published: October 25, 2005
  • DOI: 10.1371/journal.pmed.0020342

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

A C1173T Dimorphism in the VKORC1 Gene Determines Coumarin Sensitivity and Bleeding Risk

Pieter H Reitsma, Jeroen F. van der Heijden, Angelique P Groot, Frits R Rosendaal, Harry R Büller
Research Article | published 11 Oct 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020312